Documented short-term continuation rates for combined hormonal contraceptives in an indigent population with ready access to contraceptive supplies

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 6, 2007, Pages 599.e1-599.e6

  Nelson, Anita L ^a   Pietersz, Dannelle ^a   Nelson, LeRoy E ^a   Aguilera, Lucy ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

combined hormonal contraceptives; continuation rates; dispensing protocols

Indexed keywords

CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG MANUFACTURE; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; INDIGENT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; VAGINA RING;

EID: 34249654571     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.03.020     Document Type: Article

References (17)

1. World Health Organization. Selected practice recommendations for contraceptive use. 2nd ed (2004), World Health Organization, Geneva, Switzerland
2. Parsey K.S., and Pong A. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 61 (2000) 105-111
3. Bachmann G., Sulak P.J., Sampson-Landers C., Benda N., and Marr J. Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone. Contraception 70 (2004) 191-198
4. Audet M.C., Moreau M., Koltun W.D., et al., ORTHO EVRA/EVRA 004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 285 (2001) 2347-2354
5. Dieben T.O., Roumen F.J., and Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 100 (2002) 585-593
6. Bjarnadottir R.I., Tuppurainen M., and Killick S.R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 186 (2002) 389-395
7. Roumen F.J., Apter D., Mulders T.M., and Dieben T.O. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 16 (2001) 469-475
8. Schafer J.E., Osborne L.M., Davis A.R., and Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception 73 (2006) 488-492
9. Lara-Torre E., and Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception 66 (2002) 81-85
10. Cromer B.A., Smith R.D., Blair J.M., Dwyer J., and Brown R.T. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics 94 (1994) 687-694
11. Rosenberg M.J., and Waugh M.S. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 Pt 1 (1998) 577-582
12. Bakhru A., and Stanwood N. Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population. Obstet Gynecol 108 (2006) 378-386
13. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 166 (2006) 1842-1847
14. Foster D.G., Parvataneni R., de Bocanegra H.T., Lewis C., Bradsberry M., and Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol 108 (2006) 1107-1114
15. Vitzthum V.J., and Ringheim K. Hormonal contraception and physiology: a research-based theory of discontinuation due to side effects. Stud Fam Plann 36 (2005) 13-32
16. Cheung E., and Free C. Factors influencing young women's decision making regarding hormonal contraceptives: a qualitative study. Contraception 71 (2005) 426-431
17. Huber L.R., Hogue C.J., Stein A.D., et al. Contraceptive use and discontinuation: findings from the contraceptive history, initiation, and choice study. Am J Obstet Gynecol 194 (2006) 1290-1295